Navigation Links
LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
Date:7/29/2008

LegalView reported a breakthrough test on its mesothelioma blog, which will allow early detection of mesothelioma cancer. Up to this point, the number one reason mesothelioma cancer kills a patient so quickly is due to the fact that it is often misdiagnosed.

Denver, CO (PRWEB) July 30, 2008 -- LegalView, the most comprehensive legal resource available on the web, informed mesothelioma blog readers of a new scientific test that may offer early diagnosis of mesothelioma cancer. The diagnostic test is an effort between Rosetta Genomics Ltd. and the Columbia University Medical Center. The two organizations have completed the test that can determine between two similar forms of lung cancer. The research is being hailed as a breakthrough, especially for those suffering from mesothelioma cancer. Because the rare cancer often appears similar to other less deadly types of lung cancer, it can spread quickly and become fatal within a matter of months upon the misdiagnosis. Those who have mesothelioma cancer or who have lost a loved one to the disease can speak with a http://mesothelioma.legalview.com/ [mesothelioma attorney __title__ Mesothelioma Lawyer] and learn about the details of a potential http://mesothelioma.legalview.com/mesothelioma-law-suit.aspx [mesothelioma lawsuit __title__ Mesothelioma Litigation] in which monetary compensation may be awarded.

Mesothelioma is an incurable lung cancer that has been linked to the inhalation of asbestos fibers and dust. The cancer typically remains dormant within the body for years or even decades, and is often misdiagnosed because its symptoms are similar to other variations of lung cancer as well as other diseases. Individuals who have been affected by this condition can receive legal consultation and additional http://mesothelioma.legalview.com/blog [mesothelioma information __title__ Mesothelioma Lawsuit] by speaking with a http://mesothelioma.legalview.com/find-mesothelioma-lawer.aspx [mesothelioma lawyer __title__ Mesothelioma Law Firm].

For more information on this and other mesothelioma research, visit LegalView's homepage at http://www.LegalView.com/. Readers will also find a vast array of legal resources ranging from information on rare diseases, such as Nephrogenic Systemic Fibrosis (NSF), or on the latest news of controversial pharmaceutical drugs and U.S. Food and Drug Administration (FDA) recalls. Most recently, the FDA increased the labeling of a group of antibiotics -- increasing the label to a black box warning, which is considered the strongest and harshest of the FDA's labeling. Among the fluoroquinolone antibiotics are Cipro and Levaquin, the most commonly prescribed of this allegedly dangerous group of prescription drugs.

Cipro, also known as ciprofloxacin, is an antibiotic that was released in August 2000 from Bayer A.G. The antibiotic treats a multitude of bacterial infections but has been linked to several severe side effects, the most extreme being tendon rupture among patients. Specifically, patients who took the drug, whether short or long term, are subject to a high risk of Achilles tendonitis. The risk also affects individuals who took the drug anywhere from weeks before the tendon rupture to patients who may have taken the drug years prior to their tendon rupture. Individuals suffering from this condition are advised to seek legal counsel to learn about a potential http://cipro.legalview.com [Cipro class action lawsuit __title__ Cipro Attorney].

Levaquin, levofloxacin, similar to Cipro, treats several types of bacterial infections including gonorrhea, pneumonia, bronchitis, etc. The drug has also been subject to the black box labeling and the http://levaquin.legalview.com [Levaquin warning __title__ Levaquin Side Effect] includes the risk of tendon rupture among patients. Additionally, an array of harmful side effects of the antibiotic exist including: abdominal tenderness; cramping or severe pain; confusion, hallucinations or psychosis; diarrhea; fever; blisters, redness and swelling of the skin; sensation of burning skin; trembling or seizures; vomiting; easy bruising or bleeding; jaundice; numbness in limbs or tingling in fingers; swelling and pain in legs/muscles.

The FDA also recently issued a public-safety advisory on another antibiotic unrelated to the fluoroquinolone drugs known as Ketek or telithromycin. The antibiotic has been linked to severe liver damage among patients and has allegedly been the cause of nearly 18 deaths, according to FDA reports. Those who are taking the antibiotic should consult a physician immediately to determine if the prescription drug may cause harm. It is also advisable for patients to speak with an experienced pharmaceutical law firm to discuss the details of a possible http://ketek.legalview.com [Ketek lawsuit __title__ Ketek Risks], which is especially important for patients who have previously been victim to the adverse risks of the drug.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

# # #

Read the full story at http://www.prweb.com/releases/2008/07/prweb1150494.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
3. Wellcorps International Unveils New Nutritional Supplements
4. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
5. Rice unveils $100 million initiative for world health technology
6. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
7. The Well Life Center in Mesa Unveils The 10 Healing Secrets to Health & Longevity Lecture. Proceeds Benefit The Arizona Special Olympics
8. Cleveland Clinic Unveils Top 10 Medical Innovations For 2008
9. National Domestic Violence Hotline Unveils 10-Year Blueprint to Significantly Reduce Domestic Violence in America
10. GainSpan Unveils Wi-Fi(R) Sensor Network Solution With Years of Battery Life
11. U.S. Unveils Database of Genetic, Clinical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology: